Cardiovascular tissues are particularly sensitive to the compound 19
Improves the density and volume of existing hair, reducing the appearance of thinning
Tirzepatide (15mg, 72w) 20.9% Mean Reduction Retatrutide (12mg, 48w) 24.2% Mean Reduction Dosing Protocols in Laboratory Research Dosing protocols for these peptides are typically based on a "low and slow" escalation model to minimize gastrointestinal saturation
This could lead to FDA approvals for treatment in obstructive sleep apnea, kidney disease, Alzheimers disease, liver disease, PCOS, and more
Thus, following the identification of active BAT in adult humans and the demonstration that certain depots of white adipose tissue can undergo browning, there has been recent interest in the development of approaches that induce BAT activity and promote browning [10]